164 related articles for article (PubMed ID: 11477489)
21. Multidimensional nature of apomorphine SL (Ixense) therapy.
Costa P
Int J Impot Res; 2003 Apr; 15 Suppl 2():S13-5. PubMed ID: 12825099
[TBL] [Abstract][Full Text] [Related]
22. Apomorphine: an update of clinical trial results.
Heaton JP
Int J Impot Res; 2000 Oct; 12 Suppl 4():S67-73. PubMed ID: 11035390
[TBL] [Abstract][Full Text] [Related]
23. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
Mulhall JP; Bukofzer S; Edmonds AL; George M;
Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
[TBL] [Abstract][Full Text] [Related]
24. Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction.
Heaton JP; Dean J; Sleep DJ
Int J Impot Res; 2002 Feb; 14(1):61-4. PubMed ID: 11896482
[TBL] [Abstract][Full Text] [Related]
25. Challenges in oral therapy for erectile dysfunction.
Seftel AD
J Androl; 2002; 23(6):729-36. PubMed ID: 12399513
[No Abstract] [Full Text] [Related]
26. FDA committee recommends approval for viagra rival.
Gottlieb S
BMJ; 2000 Apr; 320(7242):1094. PubMed ID: 10775211
[No Abstract] [Full Text] [Related]
27. Oral and topical treatment of erectile dysfunction. Present and future.
Morales A; Heaton JP; Johnston B; Adams M
Urol Clin North Am; 1995 Nov; 22(4):879-86. PubMed ID: 7483136
[TBL] [Abstract][Full Text] [Related]
28. A historical review of erectile dysfunction.
Valiquette L
Can J Urol; 2003 Feb; 10 Suppl 1():7-11. PubMed ID: 12625844
[TBL] [Abstract][Full Text] [Related]
29. [Preclinical studies of apomorphine hydrochloride].
Ichise J; Yokokawa K
Nihon Rinsho; 2002 Jun; 60 Suppl 6():452-6. PubMed ID: 12166199
[No Abstract] [Full Text] [Related]
30. Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction.
Maclennan KM; Boshier A; Wilton LV; Shakir SA
BJU Int; 2006 Jul; 98(1):125-31. PubMed ID: 16831156
[TBL] [Abstract][Full Text] [Related]
31. Centrally acting mechanisms for the treatment of male sexual dysfunction.
Miner MM; Seftel AD
Urol Clin North Am; 2007 Nov; 34(4):483-96, v. PubMed ID: 17983889
[TBL] [Abstract][Full Text] [Related]
32. Evaluating dose regimens of apomorphine, an open-label study.
Kongkanand A; Opanuraks J; Tantiwongse K; Choeypunt N; Tantiwong A; Amornvejsukit T
Int J Impot Res; 2003 Apr; 15 Suppl 2():S10-2. PubMed ID: 12825098
[TBL] [Abstract][Full Text] [Related]
33. [Clinical evaluation of apomorphine HCl].
Nagai A; Kumon H
Nihon Rinsho; 2002 Jun; 60 Suppl 6():457-60. PubMed ID: 12166200
[No Abstract] [Full Text] [Related]
34. Central nervous system agents and erectile dysfunction.
Kumar R; Nehra A
Urol Clin North Am; 2011 May; 38(2):165-73. PubMed ID: 21621083
[TBL] [Abstract][Full Text] [Related]
35. Emerging oral drugs for erectile dysfunction.
Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
[TBL] [Abstract][Full Text] [Related]
36. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
37. Mode of action of a new oral treatment for erectile dysfunction: apomorphine SL.
Rampin O
BJU Int; 2001 Oct; 88 Suppl 3():22-4. PubMed ID: 11578275
[No Abstract] [Full Text] [Related]
38. Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction.
Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Zanoni M; Heaton JP; Rigatti P; Fazio F
Int J Impot Res; 2003 Jun; 15(3):203-9. PubMed ID: 12904807
[TBL] [Abstract][Full Text] [Related]
39. Update on oral treatments for male erectile dysfunction.
Kalsi JS; Kell PD
J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system agents in the treatment of erectile dysfunction.
Kendirci M; Walls MM; Hellstrom WJ
Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
